CytRx Corp.
(Other OTC/NBB : CYTR)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. -1.74%26.5314.1%$156.11m
HZNPHorizon Therapeutics Plc -4.51%74.975.6%$145.18m
ACRSAclaris Therapeutics, Inc. -0.91%17.484.7%$128.70m
BHCBausch Health Cos., Inc. -1.74%26.530.0%$109.30m
CTLTCatalent, Inc. -2.08%113.322.1%$104.54m
JAZZJazz Pharmaceuticals Plc -2.88%166.052.4%$86.52m
SAVACassava Sciences, Inc. 23.92%19.430.0%$69.29m
AMRNAmarin Corp. Plc -1.06%7.481.5%$62.88m
UTHRUnited Therapeutics Corp. -2.66%164.8514.1%$59.11m
ISRIsoRay, Inc. -4.09%2.112.5%$56.26m
GWPHGW Pharmaceuticals Plc 4.77%150.236.1%$55.26m
PRGOPerrigo Co. Plc 0.00%44.506.8%$53.91m
ACSTAcasti Pharma, Inc. -4.20%0.730.2%$53.14m
ARGXargenx SE -4.55%300.990.0%$50.83m
ICPTIntercept Pharmaceuticals, Inc. 1.93%33.7816.8%$43.62m

Company Profile

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.